Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
129,609,461
-
Share change
-
+10,065,549
-
Total reported value
-
$453,638,008
-
Put/Call ratio
-
156%
-
Price per share
-
$3.50
-
Number of holders
-
189
-
Value change
-
+$35,415,047
-
Number of buys
-
109
-
Number of sells
-
52
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2024
As of 30 Jun 2024,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,609,461 shares.
The largest 10 holders included
Rubric Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Velan Capital Investment Management LP, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, Tejara Capital Ltd, and PALISADE CAPITAL MANAGEMENT, LP.
This page lists
189
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.